China Proton Therapy Market to Clock a CAGR of Nearly 30% through 2025

Posted by Deeksha on January 22nd, 2019

Growing prevalence of cancer incidence in China is boosting the demand for novel and cutting edge treatment solutions such as Proton therapy. Factors increasing the demand for proton therapy in China are its usage in treating different types of cancer owing to its exceptional physical properties and superior dosimetric parameters. Proton therapy market in China is envisaged to register an impressive rise, at a CAGR of around 30% through 2025. Moreover, the market will be worth more than billion by 2025. The aforementioned insights are gleaned from a market research report titled, “China Proton Therapy Market Size, Status and Forecast to 2025,” included recently in the extensive repository of the Market Research Hub (MRH). Majority of the population in China do not have access to proton therapy owing to lack of protein therapy centers in the country. Therefore, several hospitals and research institutions have started investing more in proton therapy to make it more accessible to the patients, which is further opening up more growth avenues for the proton therapy market in China. Proton beam therapy is beneficial in curing tumor as it releases most of their energy on tumor, but causes minimal damage to nearby healthy tissue. However, researchers are working on solutions to improve the therapy by minimizing its impact on skin, which, in turn will further drive the market growth in China.

Click here for Free Sample Report@ https://www.marketresearchhub.com/enquiry.php?type=S&repid=1981197

China Proton Therapy Market: Report Summary

The primary motive of this report is to provide a brief analysis on the China proton therapy market, along with analysis on key drivers, opportunities, trends, and challenges that affect the market growth. With 2017 as base year, the report provides a precise forecast on the China proton market to the year 2025. Size of the market has been provided in terms of value (US$ Mn). Estimated values have been evaluated on the basis of total revenues of the proton therapy manufacturers. The report has also covered a detailed discussion on economic as well as technological trends affecting expansion of the China protein therapy market. The report also provides a segmental analysis of the China proton therapy market, and includes imperative market numbers such as value and volume comparison, and CAGRs of the market segments recognized in the report.

View Full Report with Table and Content@ https://www.marketresearchhub.com/pr/china-proton-therapy-market.html

China Proton Therapy Market: Contents of the Report

The report includes 20 data tables to give a forecast of the China proton therapy market. An overview of the China proton therapy market has been provided in the report, along with assessment of key application areas and technologies of China proton therapy.

A peek into the environmental concerns as well as government regulations associated with the industry has led to accurate analysis on the dynamics of the China proton therapy market. The report also provides detailed study of the competition landscape of the China proton therapy market. Key players recognized in the report are Ion Beam Applications (IBA), Hitachi, Varian, ProNova Solution, ProTom International, Mevion, and Siemens Healthneers.

New market entrants along with the existing market players will have an added advantage with the strategies of the key players covered in the final section of the China proton therapy market report.